2023 Q4 Form 10-K Financial Statement

#000161674123000042 Filed on December 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.429M $6.429M
YoY Change -22.56% -22.56%
Cash & Equivalents $6.429M $6.429M
Short-Term Investments
Other Short-Term Assets $5.506M $5.506M
YoY Change -7.52% -7.52%
Inventory $898.0K $898.0K
Prepaid Expenses
Receivables $6.126M $6.126M
Other Receivables $511.0K $511.0K
Total Short-Term Assets $19.47M $19.47M
YoY Change -5.29% -5.29%
LONG-TERM ASSETS
Property, Plant & Equipment $26.34M $29.08M
YoY Change 30.08% 28.24%
Goodwill $3.637M
YoY Change 0.0%
Intangibles $359.0K
YoY Change -35.43%
Long-Term Investments
YoY Change
Other Assets $126.0K $126.0K
YoY Change -11.27% -11.27%
Total Long-Term Assets $33.20M $33.20M
YoY Change 22.92% 22.92%
TOTAL ASSETS
Total Short-Term Assets $19.47M $19.47M
Total Long-Term Assets $33.20M $33.20M
Total Assets $52.67M $52.67M
YoY Change 10.72% 10.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.614M $2.614M
YoY Change 33.1% 33.1%
Accrued Expenses $6.443M $6.443M
YoY Change 4.68% 4.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.057M $9.057M
YoY Change 3.95% 3.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $829.0K $4.564M
YoY Change -2.93% 13.11%
Total Long-Term Liabilities $829.0K $4.564M
YoY Change -2.93% 13.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.057M $9.057M
Total Long-Term Liabilities $829.0K $4.564M
Total Liabilities $9.886M $18.34M
YoY Change 3.33% 11.95%
SHAREHOLDERS EQUITY
Retained Earnings -$6.517M
YoY Change -29.09%
Common Stock $353.0K
YoY Change 1.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.33M $34.33M
YoY Change
Total Liabilities & Shareholders Equity $52.67M $52.67M
YoY Change 10.72% 10.72%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001616741
CY2022Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0054
CY2023 PATI Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term Minimum
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum
P1Y9M18D
CY2023 PATI Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term Maximum
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum
P6Y
CY2023 PATI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Nonvested Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNonvestedOptionsWeightedAverageRemainingContractualTerm2
P6Y5M30D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36605
CY2023 dei Entity Registrant Name
EntityRegistrantName
PATRIOT TRANSPORTATION HOLDING, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2482414
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
200 W. Forsyth St
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Jacksonville
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32202
CY2023 dei City Area Code
CityAreaCode
904
CY2023 dei Local Phone Number
LocalPhoneNumber
396-5733
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $.10 par value
CY2023 dei Trading Symbol
TradingSymbol
PATI
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3553571 shares
CY2023Q1 dei Entity Public Float
EntityPublicFloat
20484376 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6429000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8302000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
63000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
68000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6126000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5296000 usd
CY2023Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
511000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
898000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1006000 usd
CY2023Q3 PATI Prepaid Tires1
PrepaidTires1
1674000 usd
CY2022Q3 PATI Prepaid Tires1
PrepaidTires1
1486000 usd
CY2023Q3 PATI Prepaid Taxes Licenses
PrepaidTaxesLicenses
380000 usd
CY2022Q3 PATI Prepaid Taxes Licenses
PrepaidTaxesLicenses
378000 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
3369000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
3927000 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
83000 usd
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
163000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
19470000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
20558000 usd
CY2023Q3 us-gaap Land
Land
1911000 usd
CY2022Q3 us-gaap Land
Land
1911000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5452000 usd
CY2022Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
4897000 usd
CY2023Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
69685000 usd
CY2022Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
66008000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
77048000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72816000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50708000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52567000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26340000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20249000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2735000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2424000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
359000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
556000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
142000 usd
CY2023Q3 us-gaap Assets
Assets
52667000 usd
CY2022Q3 us-gaap Assets
Assets
47566000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2614000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1964000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
594000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4490000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3208000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
918000 usd
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1053000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
382000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1010000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
653000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
884000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9057000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8713000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2459000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1705000 usd
CY2023Q3 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
4715000 usd
CY2022Q3 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
3631000 usd
CY2023Q3 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
1276000 usd
CY2022Q3 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
1476000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
829000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
854000 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 PATI Preferred Stock Shares Authorized Series A Junior
PreferredStockSharesAuthorizedSeriesAJunior
250000 shares
CY2022Q3 PATI Preferred Stock Shares Authorized Series A Junior
PreferredStockSharesAuthorizedSeriesAJunior
250000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3526489 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3526489 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3484004 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3484004 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
353000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
348000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40430000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39958000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6517000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9190000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
65000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
71000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
34331000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31187000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52667000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47566000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94785000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
87882000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
81268000 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
43493000 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
37906000 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
36198000 usd
CY2023 us-gaap Fuel Costs
FuelCosts
11971000 usd
CY2022 us-gaap Fuel Costs
FuelCosts
13288000 usd
CY2021 us-gaap Fuel Costs
FuelCosts
9630000 usd
CY2023 PATI Repairs And Tire Expense
RepairsAndTireExpense
6102000 usd
CY2022 PATI Repairs And Tire Expense
RepairsAndTireExpense
5760000 usd
CY2021 PATI Repairs And Tire Expense
RepairsAndTireExpense
5402000 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3125000 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3027000 usd
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3270000 usd
CY2023 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
7064000 usd
CY2022 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
8167000 usd
CY2021 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
7261000 usd
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
5410000 usd
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
5537000 usd
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
6654000 usd
CY2023 PATI Rent Tags And Utilities
RentTagsAndUtilities
2578000 usd
CY2022 PATI Rent Tags And Utilities
RentTagsAndUtilities
2650000 usd
CY2021 PATI Rent Tags And Utilities
RentTagsAndUtilities
2708000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10592000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9306000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8764000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2215000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2011000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1936000 usd
CY2023 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-0 usd
CY2022 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
8330000 usd
CY2021 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
1614000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1047000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
739000 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-179000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
91503000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
78583000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
80388000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
3282000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
9299000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
880000 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
324000 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
62000 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
5000 usd
CY2023 us-gaap Interest Expense
InterestExpense
18000 usd
CY2022 us-gaap Interest Expense
InterestExpense
18000 usd
CY2021 us-gaap Interest Expense
InterestExpense
27000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3588000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9343000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
858000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
915000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2153000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2673000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7190000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
625000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3515000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3459000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3395000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3594000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3623000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3408000 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2673000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7190000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
625000 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-11000 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-13000 usd
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-16000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2667000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7172000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
609000 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
45048000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
248000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
219000 usd
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
3.00
CY2021 us-gaap Dividends Cash
DividendsCash
10132000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
625000 usd
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-16000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
36116000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
36116000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
212000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
315000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
180000 usd
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
3.75
CY2022 us-gaap Dividends Cash
DividendsCash
12808000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7190000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-13000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31187000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31187000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
163000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
197000 usd
CY2023 PATI Stock Expired During Period Value
StockExpiredDuringPeriodValue
10000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2673000 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000 usd
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-11000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
34331000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2673000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7190000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
625000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6027000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6106000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7202000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
925000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
960000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1015000 usd
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1084000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-431000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1025000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1057000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9130000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1472000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
360000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
392000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
467000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
830000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
366000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-108000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
135000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-448000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-724000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2007000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6000 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-28000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1169000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-409000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-682000 usd
CY2023 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-1105000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
331000 usd
CY2021 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-21000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-713000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-905000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1079000 usd
CY2023 PATI Increase Decrease In Insurance Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInInsuranceLiabilitiesAndOtherNoncurrentLiabilities
-225000 usd
CY2022 PATI Increase Decrease In Insurance Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInInsuranceLiabilitiesAndOtherNoncurrentLiabilities
-86000 usd
CY2021 PATI Increase Decrease In Insurance Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInInsuranceLiabilitiesAndOtherNoncurrentLiabilities
-370000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8872000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4235000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2772000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12088000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5248000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
910000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1226000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10909000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3083000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10862000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5661000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2173000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
12808000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
10132000 usd
CY2023 PATI Stock Expired During Period Value
StockExpiredDuringPeriodValue
10000 usd
CY2022 PATI Stock Expired During Period Value
StockExpiredDuringPeriodValue
-0 usd
CY2021 PATI Stock Expired During Period Value
StockExpiredDuringPeriodValue
-0 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
127000 usd
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
315000 usd
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
124000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12493000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10008000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1873000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2597000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5063000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8302000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10899000 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15962000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6429000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8302000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10899000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
16000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
16000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
25000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
934000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
2248000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
1273000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1236000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1453000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_844_eus-gaap--NatureOfOperations_z4sIKSwFCXb5" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"><span id="xdx_863_zWEQY6FCWpH2">DESCRIPTION OF BUSINESS</span> - The business of the Company, conducted through our wholly owned subsidiary, Florida Rock &amp; Tank Lines, Inc., is to transport petroleum and other liquids and dry bulk commodities. We do not own any of the products we haul, rather, we act as a third-party carrier to deliver our customers’ products from point A to point B predominately using Company employees driving Company owned tractors and tank trailers. Approximately <span id="xdx_906_ecustom--PercentageofBusiness_iI_dp_c20230930__srt--ProductOrServiceAxis__custom--PetroleumProductsMember_zrWK12Joxzl1" title="Percent of petroleum based business">86</span>% of our business consists of hauling liquid petroleum products (mostly gas and diesel fuel) from large scale fuel storage facilities to our customers’ retail outlets (e.g. convenience stores, truck stops and fuel depots) where we off-load the product into our customers’ fuel storage tanks for ultimate sale to the retail consumer. The remaining <span id="xdx_909_ecustom--PercentageofBusiness_iI_dp_c20230930__srt--ProductOrServiceAxis__custom--OtherProductsMember_zEz4Klfeszd9" title="Percent of other than petroleum based business">14</span>% of our business consists of hauling our customers’ dry bulk commodities such as cement, lime and various industrial powder products, water and liquid chemicals. Our operations are comprised of <span id="xdx_90D_eus-gaap--NumberOfReportableSegments_dc_c20221001__20230930_zUPtpkwFuOOf" title="Number of segments">one</span> reportable segment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> </p>
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
508000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
497000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
449000 usd
CY2023 PATI Ppe Useful Lives Text Table Block
PPEUsefulLivesTextTableBlock
<p id="xdx_893_ecustom--PPEUsefulLivesTextTableBlock_zN5YkuoOlWA6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> <span id="xdx_8B2_zrBswhT2hwqi" style="display: none">Estimated useful lives</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Tahoma, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="layout-grid-mode: line"> </td> <td style="layout-grid-mode: line"> </td> <td style="layout-grid-mode: line"> </td> <td style="layout-grid-mode: line; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Years</span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 80%; layout-grid-mode: line"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building and improvements</span></td> <td style="width: 2%; layout-grid-mode: line"> </td> <td style="width: 2%; layout-grid-mode: line"> </td> <td id="xdx_985_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20221001__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingAndBuildingImprovementsMember_z3fBVotObxu8" style="width: 16%; layout-grid-mode: line; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">7-39</span></td></tr> <tr style="vertical-align: bottom"> <td style="layout-grid-mode: line"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Revenue equipment</span></td> <td style="layout-grid-mode: line"> </td> <td style="layout-grid-mode: line"> </td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20221001__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--TransportationEquipmentMember_zqDsGG6zQ8fc" style="layout-grid-mode: line; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">7-10</span></td></tr> <tr style="vertical-align: bottom"> <td style="layout-grid-mode: line"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other equipment</span></td> <td style="layout-grid-mode: line"> </td> <td style="layout-grid-mode: line"> </td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20221001__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OtherMachineryAndEquipmentMember_zqByaGbPjYob" style="layout-grid-mode: line; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3-10</span></td></tr> </table>
CY2023 us-gaap Depreciation
Depreciation
5828000 usd
CY2022 us-gaap Depreciation
Depreciation
5904000 usd
CY2021 us-gaap Depreciation
Depreciation
7014000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
741000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3530000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
418000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3112000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
599867 shares
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 PATI Self Insurance Retention
SelfInsuranceRetention
$250,000 to $500,000
CY2023 us-gaap Health Care Organization Stop Loss Insurance Premium Expense
HealthCareOrganizationStopLossInsurancePremiumExpense
250000 usd
CY2023 PATI Health Insurance Self Insured Per Participant Per Year Aggregate
HealthInsuranceSelfInsuredPerParticipantPerYearAggregate
84500 usd
CY2023 us-gaap Health Care Organization Stop Loss Insurance Premium Expense
HealthCareOrganizationStopLossInsurancePremiumExpense
250000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_ztjVNSRjxfV6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"><span id="xdx_86F_zyiAErmWuCJ4">USE OF ESTIMATES</span> - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify">Certain accounting policies and estimates are of more significance in the financial statement preparation process than others. The most critical accounting policies and estimates include the economic useful lives and salvage values of our vehicles and equipment, impairment of tangible and intangible assets, provisions for uncollectible accounts receivable, estimates of exposures related to our insurance claims plans, and estimates for taxes. To the extent that actual, final outcomes are different than these estimates, or that additional facts and circumstances result in a revision to these estimates, earnings during that accounting period will be affected.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> </p>
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
392000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
467000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
150426 shares
CY2023Q3 PATI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Nonvested Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNonvestedOptionsWeightedAverageExercisePrice1
6.15
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
910000 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
923000 usd
CY2021 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1207000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2735000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2424000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
653000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
884000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2459000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1705000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
773000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
562000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3515000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3459000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3395000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
79000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
164000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3594000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3623000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3408000 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2673000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7190000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
625000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160483 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58884 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10611 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.38
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.53
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.014
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
360000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.77
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
750293 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.44
CY2023Q3 us-gaap Share Price
SharePrice
8.18
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
4000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-248000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2365000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
955000 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
77000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
213000 usd
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
297000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-171000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2578000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1252000 usd
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1086000 usd
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-425000 usd
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1019000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
915000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2153000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
752000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1957000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
179000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
196000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
320000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
38000 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-33000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-124000 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
16000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
915000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2153000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
5269000 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4190000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
990000 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
1044000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6259000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5234000 usd
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
466000 usd
CY2022Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
551000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1078000 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1052000 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1544000 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1603000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4715000 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3631000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
918000 usd
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1053000 usd
CY2023Q3 PATI Prepaid Insurance Claims
PrepaidInsuranceClaims
1868000 usd
CY2022Q3 PATI Prepaid Insurance Claims
PrepaidInsuranceClaims
2285000 usd
CY2023Q3 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
1276000 usd
CY2022Q3 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
1476000 usd
CY2023Q3 PATI Accrued Insurance Liability Prepaid Net
AccruedInsuranceLiabilityPrepaidNet
326000 usd
CY2022Q3 PATI Accrued Insurance Liability Prepaid Net
AccruedInsuranceLiabilityPrepaidNet
244000 usd
CY2023Q3 PATI Captive Insurance Assets
CaptiveInsuranceAssets
2327000 usd
CY2022Q3 PATI Captive Insurance Assets
CaptiveInsuranceAssets
3672000 usd
CY2023Q3 PATI Gross Insurance Liability
GrossInsuranceLiability
2653000 usd
CY2022Q3 PATI Gross Insurance Liability
GrossInsuranceLiability
3916000 usd
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
487000 usd
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
447000 usd
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
482000 usd
CY2023 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
13000 usd
CY2022 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
15000 usd
CY2021 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
17000 usd
CY2023Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent
363000 usd
CY2022Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent
416000 usd
CY2023Q3 us-gaap Other Postretirement Benefits Payable Current And Noncurrent
OtherPostretirementBenefitsPayableCurrentAndNoncurrent
283000 usd
CY2022Q3 us-gaap Other Postretirement Benefits Payable Current And Noncurrent
OtherPostretirementBenefitsPayableCurrentAndNoncurrent
267000 usd
CY2023 us-gaap Other Postretirement Benefit Expense
OtherPostretirementBenefitExpense
-2000 usd
CY2022 us-gaap Other Postretirement Benefit Expense
OtherPostretirementBenefitExpense
-5000 usd
CY2021 us-gaap Other Postretirement Benefit Expense
OtherPostretirementBenefitExpense
-8000 usd
CY2023 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.040
CY2022 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.040
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.030
CY2023Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.050
CY2022Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.040
CY2021Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.030
CY2023 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p id="xdx_803_eus-gaap--LossContingencyDisclosures_zpPiUjOq8Ojb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"><b>11. <span id="xdx_823_zGaUM3uhZE38">Contingent Liabilities</span>.</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify">The Company is involved in litigation on a number of matters and is subject to certain claims which arise in the normal course of business. The Company has retained certain self-insurance risks with respect to losses for third party liability and property damage. There is a reasonable possibility that the Company’s estimate of vehicle and workers’ compensation liability may be understated or overstated but the possible range cannot be estimated. The liability at any point in time depends upon the relative ages and amounts of the individual open claims. In the opinion of management none of these matters are expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2pt 0 0; text-align: justify"> </p>
CY2020Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2021Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2022Q3 us-gaap Goodwill
Goodwill
3637000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4586000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4227000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4586000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4030000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
197000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
133000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
44000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
44000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
44000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
44000 usd
CY2023Q3 PATI Finite Lived Intangible Assets Amortization Expense Five Year Total
FiniteLivedIntangibleAssetsAmortizationExpenseFiveYearTotal
309000 usd
CY2023 dei Auditor Name
AuditorName
Hancock Askew & Co., LLP
CY2023 dei Auditor Location
AuditorLocation
Jacksonville, Florida
CY2023 dei Auditor Firm
AuditorFirmId
794

Files In Submission

Name View Source Status
0001616741-23-000042-index-headers.html Edgar Link pending
0001616741-23-000042-index.html Edgar Link pending
0001616741-23-000042.txt Edgar Link pending
0001616741-23-000042-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pati-20230930.xsd Edgar Link pending
pati10k23.htm Edgar Link pending
pati10k23.pdf Edgar Link pending
patiex23.htm Edgar Link pending
patiex31a.htm Edgar Link pending
patiex31b.htm Edgar Link pending
patiex31c.htm Edgar Link pending
patiex32.htm Edgar Link pending
patiex97.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
pati-20230930_cal.xml Edgar Link unprocessable
pati-20230930_pre.xml Edgar Link unprocessable
pati-20230930_lab.xml Edgar Link unprocessable
pati-20230930_def.xml Edgar Link unprocessable
pati10k23_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable